Angiographic Signatures of the Predominant Form of Familial Transthyretin Amyloidosis (Val30Met Mutation).

MLA

Rousseau, Antoine, et al. “Angiographic Signatures of the Predominant Form of Familial Transthyretin Amyloidosis (Val30Met Mutation).” American Journal of Ophthalmology, vol. 192, Aug. 2018, pp. 169–77. EBSCOhost, https://doi.org/10.1016/j.ajo.2018.05.023.

APA

Rousseau, A., Terrada, C., Touhami, S., Barreau, E., Rothschild, P.-R., Valleix, S., Benoudiba, F., Errera, M.-H., Cauquil, C., Guiochon-Mantel, A., Adams, D., & Labetoulle, M. (2018). Angiographic Signatures of the Predominant Form of Familial Transthyretin Amyloidosis (Val30Met Mutation). American Journal of Ophthalmology, 192, 169–177. https://doi.org/10.1016/j.ajo.2018.05.023

Chicago

Rousseau, Antoine, Céline Terrada, Sara Touhami, Emmanuel Barreau, Pierre-Raphaël Rothschild, Sophie Valleix, Farida Benoudiba, et al. 2018. “Angiographic Signatures of the Predominant Form of Familial Transthyretin Amyloidosis (Val30Met Mutation).” American Journal of Ophthalmology 192 (August): 169–77. doi:10.1016/j.ajo.2018.05.023.